Peptide-based hydrogels as delivery systems for doxorubicin.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide-based hydrogels as delivery systems for doxorubicin.
- Published In:
- Journal of peptide science : an official publication of the European Peptide Society, 28(1), e3301 (2022)
- Database ID:
- RPEP-06088
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06088APA
Diaferia, Carlo; Rosa, Elisabetta; Accardo, Antonella; Morelli, Giancarlo. (2022). Peptide-based hydrogels as delivery systems for doxorubicin.. Journal of peptide science : an official publication of the European Peptide Society, 28(1), e3301. https://doi.org/10.1002/psc.3301
MLA
Diaferia, Carlo, et al. "Peptide-based hydrogels as delivery systems for doxorubicin.." Journal of peptide science : an official publication of the European Peptide Society, 2022. https://doi.org/10.1002/psc.3301
RethinkPeptides
RethinkPeptides Research Database. "Peptide-based hydrogels as delivery systems for doxorubicin." RPEP-06088. Retrieved from https://rethinkpeptides.com/research/diaferia-2022-peptidebased-hydrogels-as-delivery
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.